Enfortumab Vedotin Prolongs Survival in Advanced Urothelial Cancer
Overall survival longer compared with standard chemo for disease progression following platinum-based chemo and PD-1 or PD-L1 inhibitor
Certain Prostate Drugs Tied to Risk for Parkinson Disease
Use of glycolysis-enhancing drugs terazosin, doxazosin, or alfuzosin tied to lower risk for developing Parkinson disease than use of tamsulosin
Decrease Seen in U.S. Life Expectancy in First Half of 2020
Life expectancy decreased by 1.0 year in first half of 2020 from 2019, with decreases of 1.2 and 0.9 years for males and females, respectively
FDA Approves Therapy to Protect Bone Marrow Cells From Effects of Chemotherapy
Cosela reduces the frequency of bone marrow suppression caused by chemotherapy for extensive-stage small cell lung cancer
Avacopan Noninferior to Prednisone for ANCA-Associated Vasculitis
Avacopan noninferior to prednisone taper for remission at week 26, superior to prednisone taper for sustained remission at week 52
Biomarker May Predict Treatment Outcome in Advanced Melanoma
Changes in plasma levels of ctDNA associated with survival outcomes in BRAF V600 mutation-positive unresectable or metastatic melanoma
Primary PCI Use Down for Cancer Patients With STEMI
Rates of associated in-hospital all-cause mortality, major adverse cardiovascular and cerebrovascular events lower for cancer patients
Cabozantinib Prolongs PFS in Papillary Renal Cell Carcinoma
Progression-free survival longer and response rate greater for cabozantinib versus sunitinib in phase 2 trial in adults with PRCC
Factors Other Than Workplace Tied to COVID-19 Positivity in HCWs
Demographic, community factors show stronger influence than workplace exposure on COVID-19 risk in health care workers
Mammography Guidelines Developed for Older Breast Cancer Survivors
Discontinuation of routine mammography recommended for breast cancer survivors when life expectancy is less than five years
